Only 7 out of 500 publicly-traded companies in the U.S. gained value last week, according to the Wall Street Journal — including Clorox, the disinfectant manufacturer, and Gilead Sciences and Regeneron, which are working on coronavirus treatments.

Other noteworthy stock gainers throughout the stock market’s jittery run include other pharma companies — like Moderna, whose vaccine is in the midst of an early clinical trial — and tech companies that connect people when movement around the globe is limited, like Zoom, Teledoc and Dropbox.

Peloton, whose home exercise bikes save people trips to germ-laden gyms, briefly saw its shares spike amid the broader market’s sell-off.

Conversely, travel companies — like the major cruise lines, plus big airlines and hotel chains — have been punished.